BrainVectis
Developing gene therapy treatments for neurodegenerative diseases by targeting the cholesterol pathway in the brain.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD7—10m (Dealroom.co estimates Sep 2016.)
Company register number 813073517
Paris Île-de-France (HQ)
Authorizing premium user...